Changchun BCHT Biotechnology Co.

¥16.18As of Sun 8 Nov 2026, 12:00 UTC
SSE:688276Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (29.20%)
Div yield —
ROE (5.19%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.20
PE TTM —
TSR TTM (26.05%)
Mkt cap ¥6.693B
ROIC (4.71%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥19
17.12%
(11.03%)
Hold 0|7|3|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.15
0.16
0.17
(2.92%)
(6.91%)
3.55%
11.55%
Revenue¥M
864.1
893.0
909.2
935.5
4.36%
4.59%
5.63%
11.81%
Peers (US$1.003B)
Cap (US$)
PE
996.4M
30.31x
1.008B
—
Capital
TTM
5Y
10Y
Leveragex
0.442
0.345
0.212
EBIT/Intx
0.530
0.295
0.251
Own earn%
14.48
65.99
102.08
Sh yield%
16.45
27.50
27.03
Owners
Insiders/Inst%
12.34
77.48
Short interest%
2.01
SBC / revenue%
2.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
14–24
$1 testx
—
Incr. ROIC%
11